On July 24, 2024, the Commerce Department’s Bureau of Industry and Security (BIS) announced amendments to the U.S. Export Administration…
Read More →
Case Name: Salix Pharms., Ltd. v. Norwich Pharms. Inc., No. 2022-2153, 2023-1952, 2024 WL 1561195 (Fed. Cir. Apr. 11, 2024)…
Read More →
Precedential and Key Federal Circuit Opinions – 1. BACKERTOP LICENSING LLC [OPINION] (23-2367, 23-2368, 24-1016, 24-1017 Prost, Hughes, and Stoll) –…
Read More →
In response to the rise of the use of artificial intelligence (AI) technologies in telecommunications, on July 17, 2024, the…
Read More →
On July 25, 2024, Representative Roger Williams, Chairman of the House Committee on Small Business (the “Committee”), informed Consumer Product…
Read More →
Analyst reaction to D-Wave Quantum’s announcement today of an extended product development roadmap aimed at helping organizations address a variety…
Read More →
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing…
Read More →
In June 2024, the U.S. Food and Drug Administration (“FDA”) clarified, with respect to the Drug Supply Chain Security Act…
Read More →
The UK prioritizes a flexible framework over comprehensive regulation and emphasizes sector-specific laws. Laws/Regulations directly regulating AI (the “AI Regulations”)…
Read More →
This Holland & Knight blog post is the second installment in a two-part series that examines the challenges to the…
Read More →